Novartis Claims $4 Million Is Reasonable Price For Single Treatment With New Gene Therapy

NEWS Drug company Novartis claims that $4 million is a reasonable price for a single treatment with its new gene therapy for spinal muscular atrophy. COMMENT … Continue reading Novartis Claims $4 Million Is Reasonable Price For Single Treatment With New Gene Therapy